Apple juice improved behavioral but not cognitive symptoms in moderate-to-late stage Alzheimer's disease in an open-label pilot study

American Journal of Alzheimer's Disease and other Dementias

Volumn 25, Issue 4, 2010, Pages 367-371

  Remington, Ruth ^a   Chan, Amy ^a   Lepore, Alicia ^a   Kotlya, Elizabeth ^a   Shea, Thomas B ^a,b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b University of Massachusetts Lowell   (United States)

Author keywords

Alzheimer's disease; Behavioral symptoms; Fruit; Nutrition; Supplement

Indexed keywords

AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY; APPLE JUICE; ARTICLE; BEHAVIOR CHANGE; CAREGIVER; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; DELUSION; DEMENTIA; DISEASE SEVERITY; HUMAN; PSYCHOSIS; BEHAVIOR; BEVERAGE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DIET SUPPLEMENTATION; DIET THERAPY; HOME FOR THE AGED; MALUS; NEUROPSYCHOLOGICAL TEST; NURSING HOME; PROSPECTIVE STUDY; PSYCHOLOGY; TIME; UNITED STATES; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; BEVERAGES; CAREGIVERS; COGNITION; DIETARY SUPPLEMENTS; HOMES FOR THE AGED; HUMANS; MALUS; MASSACHUSETTS; NEUROPSYCHOLOGICAL TESTS; NURSING HOMES; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 77953648613     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317510363470     Document Type: Article

References (62)

1. Swerdlow RH Pathogenesis of Alzheimer's disease. Clin Interv Aging. 2007 ; 2 (3). 347-359.
2. Shah S., Reichman WE Treatment of Alzheimer's disease across the spectrum of severity. Clin Interv Aging. 2006 ; 1 (2). 131-142.
3. Burns A., Gauthier S., Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2007 ; 22 (8). 806-812.
4. Feldman HH, Schmitt FA, Olin JT Memantine MEM-MD-02 Study Group. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment. Alzheimer Dis Assoc Disord. 2006 ; 20 (4). 263-268.
5. Johannsen P. Medical treatment of Alzheimer's disease. Ugeskr Laeger. 2006 ; 168 (40). 3424-3429.
6. Reisberg B., Doody R., St¶ffler A., Schmitt F., Ferris S., M¶bius HJ A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol. 2006 ; 63 (1). 49-54.
7. Seow D., Gauthier S. Pharmacotherapy of Alzheimer disease. Can J Psychiatry. 2007 ; 52 (10). 620-629.
8. Beier MT Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Pharmacotherapy. 2007 ; 27 (3). 399-411.
9. Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS Is functional decline necessary for a diagnosis of Alzheimer's disease ? Dement Geriatr Cogn Disord. 2007 ; 24 (5). 375-379.
10. Touchon J., Portet F., Gauthier S. Prevention trials in Alzheimer disease: one step forward? Neurology. 2006 ; 67 (9suppl 3). S21 - S22.
11. Fusco D., Colloca G., Lo Monaco MR, Cesari M. Effects of antioxidant supplementation on the aging process. Clin Interv Aging. 2007 ; 2 (3). 377-387.
12. Mattson MM, Shea TB Folate and Homocysteine in Neural Plasticity and Neurodegenerative Disorders. Trends Neurosci. 2003 ; 26 (3). 137-146.
13. Burgener SC, Buettner L., Coen Buckwlater K., et al. Evidence supporting nutritional interventions for persons in early-stage Alzheimer's disease. J Nutr Health Aging. 2008 ; 12 (1). 18-21.
14. Panza F., Solfrizzi V., Colacicco AM, D'Introno A., Capurso C., Torres F. Mediterranean diet and cognitive decline. Pub Health Nutri. 2004 ; 7 (7). 959-963.
15. Zhu X., Su B., Wang X., Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci. 2007 ; 64 (17). 2202-2210. (Pubitemid 47347959)
16. Joseph JA, Denisova NA, Bielinski D., Fisher DR, Shukitt-Hale. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention. Mech Aging Devel. 2000 ; 116 (2-3). 141-153.
17. Ames BN Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A. 2006 ; 103 (47). 17589-17594.
18. Arnaud-Battandier F., Malvy D., Jeandel C., et al. Use of oral supplements in malnourished elderly patients living in the community: a pharmaco-economic study. Clin Nutr. 2004 ; 23 (5). 1096-1103.
19. Elmadfa I., Meyer AL (2008) Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab. 52 (suppl 1). 2-5.
20. Chan A., Paskavitz J., Remington R., Shea TB Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a one-year open-label pilot study with an 16-month extension. Am J Alz eimers Dis Other Dement. 2008 ; 23 (6). 571-585.
21. Remington R., Chan A., Shea TB Efficacy of a vitamin/nutriceutical formulation for moderate to late-stage Alzheimer's disease: A placebo-controlled pilot study. Am J Alzheimers Dis Other Dement. 2009 ; 24 (1). 27-33.
22. Chan A., Lepore A., Kotoya E., Zemianek J., Remington R., Shea TB Efficacy of a vitamin/nutriceutical formulation on cognitive speed and recall in adults with no known or suspected dementia. J Nutri Health Aging. 2009 ; in press.
23. Ortiz D., Shea TB Apple juice prevents oxidative stress induced by amyloid-beta in culture. J Alzheimers Dis. 2004 ; 6 (1). 27-30.
24. Rogers EJ, Mihalick S., Ortiz D., Shea TB Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J Nutr Health Aging. 2004 ; 8 (2). 92-97.
25. Tchantchou F., Graves M., Ortiz D., Rogers E., Shea TB Dietary supplementation with apple juice concentrate alleviates the compensatory increase in glutathione synthase transcription and activity that accompanies dietary-and genetically-induced oxidative stress. J Nutri Health Aging. 2004 ; 8 (6). 492-496.
26. Tchantchou F., Chan A., Kifle L., Ortiz D., Shea TB Apple juice concentrate prevents oxidative damage and cognitive decline in aged mice. J Alzheimers Dis. 2005 ; 8 (3). 283-287.
27. Chan A., Graves V., Shea TB Apple juice concentrate maintains acetylcholine levels following dietary compromise. J Alzheimers Dis. 2006 ; 9 (3). 287-291.
28. Chan A., Shea TB Supplementation with apple juice attenuates presenilin-1 overexpression during dietary and genetically-induced oxidative stress. J Alzheimers Dis. 2006 ; 10 (4). 353-358.
29. Chan A., Shea TB Supplementation with apple juice decreases endogenous Abeta levels in murine brain. J Alzhe mer Dis. 2009 ; 16 (1). 167-171.
30. Serra M., Shea TB Apple juice stimulates organized synaptic activity in cultured cortical neurons. Current Topics Nutraceutical Res. 2009 ; in press.
31. Mckhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984 ; 34 (7). 939-944.
32. Lucas JA, Ivnik RJ, Smith GE, et al. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsy. 1993 ; 20 (4). 536-547.
33. Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol. 1995 ; 52 (9). 899-904.
34. Cummings JL The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997 ; 48 (5 suppl 6). S10 - S16.
35. Galasko D., Bennett D., Sano M., et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997 ; 11 (suppl 2). S33 - S39.
36. Potkin SG The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patients. Int Psychogeriatr. 2002 ; (14 suppl 1). 7-26.
37. Cohen J. Statistical Power Analysis For The Behavioral Sciences. 2 nd ed. Hillsdale, NJ: Lawrence Erlbaum ; 1988.
38. Wolfe KL, Kang X., He X., Dong M., Zhang Q., Liu RH Cellular antioxidant activity of common fruits. J Agric Food Chem. 2008 ; 56 (18). 8418-8426.
39. He X., Liu RH Phytochemicals of apple peels: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J Agric Food Chem. 2008 ; 56 (21). 9905-9910
40. Staehelin HB Neuronal protection by bioactive nutrients. Int J Vitam Nutr Res. 2008 ; 78 (6). 282-285.
41. Bouchard RW, Rossor M. Typical clinical features. In: Gauthier S, ed. Clinical Diagnosis and Management of Alzheimer's Disease. London: Martin Dunitz Ltd; 1996: 35-51.
42. Conn D., Thorpe L. Assessment of behavioural and psychological symptoms associated with dementia. Can J Neurol Sci. 2007 ; 34 (suppl 1). S67 - S71.
43. Craig D., Mirakhur A., Hart DJ, McIlroy SP, Passmore AP A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am J Geriatr Psychiatry. 2005 ; 13 (6). 460-468.
44. Hinchcliffe AC, Hyman IL, Blizard B., Livingston G. Behavioural complications of dementia-can they be treated ? Int Geriatr Psychiatry. 1995 ; 10 (10). 839-847.
45. Matsumoto N., Ikeda M., Fukuhara R., et al. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Dement Geriatr Cogn Disord. 2007 ; 23 (4). 219-224.
46. de Vugt ME, Riedijk SR, Aalten P., Tibben A., van Swieten JC, Verhey FR Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord. 2006 ; 22 (1). 35-41.
47. Sachs GS A review of agitation in mental illness: burden of illness and underlying pathology. J Clin Psychiatry. 2006 ; 67 (suppl 10). 5-12.
48. Shin IS, Carter M., Masterman D., Fairbanks L., Cummings JL Neuropsychiatric symptoms and quality of life in Alzheimer disease. Am J Geriatr Psychiatry. 2005 ; 13 (6). 469-474.
49. Paton J., Johnston K., Katona C., Livingston G. What causes problems in Alzheimer's disease: attributions by caregivers. A qualitative study. Int J Geriatr Psychiatry. 2004 ; 19 (6). 527-532.
50. Riello R., Geroldi C., Zanetti O., Frisoni GB Caregiver's distress is associated with delusions in Alzheimer's patients. Behav Med. 2002 ; 28 (3). 92-98.
51. Buhr GT, White HK Difficult behaviors in long-term care patients with dementia. J Am Med Dir Assoc. 2007 ; 8 (3 suppl 2). e101 - e113.
52. Sourial R., McCusker J., Cole M., Abrahamowicz M. Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden. Int Psychogeriatr. 2001 ; 13 (2). 183-197.
53. Aalten P., Verhey FR, Boziki M., et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008 ; 25 (1). 1-8.
54. Denny A. Tackling malnutrition among older people in the community. Br J Community Nurs. 2007 ; 12 (3). 98.
55. Mucci E., Jackson SH Nutritional supplementation in community-dwelling elderly people. Ann Nutr Metab. 2008 ; 52 (suppl 1). 33-37.
56. Patel MD, Martin FC Why don't elderly hospital inpatients eat adequately? J Nutr Health Aging. 2008 ; 12 (4). 227-231.
57. Kagansky N., Berner Y., Koren-Morag N., Perelman L., Knobler H., Levy S. Poor nutritional habits are predictors of poor outcome in very old hospitalized patients. Am J Clin Nutr. 2005 ; 82 (4). 784-791.
58. Monji A., Tokait M., Samejima T., et al. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuro-Psych Biol Psych. 2009 ; 33 (2). 308-311.
59. Dai Q., Borenstein AR, Wu Y., Jackson JC, Larson EB Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med. 2006 ; 119 (9). 751-759.
60. Burgener SC, Buettner L., Coen Buckwalter K., et al. Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease. J Nutr Health Aging. 2008 ; 12 (1). 18-21.
61. Kivipelto M., Solomon A. Alzheimer's disease-the ways of prevention. J Nutr Health Aging. 2008 ; 12 (1). 89S - 94S.
62. Patterson C., Feightner JW, Garcia A., Hsiung GY, MacKnight C., Sadovnick AD Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ. 2008 ; 178 (5). 548-556.